Overview
- The company’s shares climbed roughly 30% in premarket trading Wednesday after Aehr reported a fiscal fourth-quarter beat and issued FY2027 guidance of $130 million to $150 million.
- Aehr posted Q4 revenue of $18.84 million and adjusted EPS of $0.11, reversing recent weakness and producing GAAP net income of $1.4 million for the quarter.
- Quarterly bookings hit a company record of $60.7 million and the reported backlog was $80.6 million, with an effective backlog of about $100.6 million after post‑period orders.
- Management said demand is shifting from silicon carbide/EV testing to AI processors, silicon photonics and power semiconductors and highlighted product milestones including 12+ GaN WaferPak designs in customer evaluation and a 300 mm GaN wafer‑level burn‑in solution.
- Aehr ended the year with $116.5 million in cash, which management says supports scaling, but the outlook depends on converting the enlarged backlog and executing production ramps without capacity or delivery setbacks.